Biomedical Engineering and Medicines of the Future
May 24
9:00AM – 10:00AM
Sheffield-Sterling-Strathcona Hall | Room: 114 — 1 Prospect Street
Mark Saltzman, Goizueta Foundation Professor of Chemical and Biomedical Engineering; Head of Jonathan Edwards College
The practice of medicine has changed dramatically in our lifetimes, and even greater changes are anticipated in the next 20 years. Drug delivery is one area of substantial progress, and engineering principles have played an essential role in this progress. Drugs have long been used to improve health and extend lives, but a number of new modes of drug delivery, which were made possible primarily through the work of engineers, have entered clinical practice recently. In addition, engineers have contributed substantially to our understanding of the physiological barriers to efficient drug delivery such as transport in the microcirculation and drug movement through cells and tissues. Still, with all of this progress, many drugs – even drugs discovered using the most advanced molecular biology strategies – have unacceptable side effects. Side effects limit our ability to design drug treatments for cancer, neurodegenerative, and infectious diseases. This lecture will discuss an alternate strategy for drug delivery, which is based on physical targeting, or placement of the delivery system at the target site. The effectiveness of this approach will be illustrated with examples of new treatments for cancer, cardiovascular, and infectious disease.
Add to Calendar
2019-05-24T09:00:00
2019-05-24T10:00:00
Biomedical Engineering and Medicines of the Future
Mark Saltzman, Goizueta Foundation Professor of Chemical and Biomedical Engineering; Head of Jonathan Edwards College
The practice of medicine has changed dramatically in our lifetimes, and even greater changes are anticipated in the next 20 years. Drug delivery is one area of substantial progress, and engineering principles have played an essential role in this progress. Drugs have long been used to improve health and extend lives, but a number of new modes of drug delivery, which were made possible primarily through the work of engineers, have entered clinical practice recently. In addition, engineers have contributed substantially to our understanding of the physiological barriers to efficient drug delivery such as transport in the microcirculation and drug movement through cells and tissues. Still, with all of this progress, many drugs – even drugs discovered using the most advanced molecular biology strategies – have unacceptable side effects. Side effects limit our ability to design drug treatments for cancer, neurodegenerative, and infectious diseases. This lecture will discuss an alternate strategy for drug delivery, which is based on physical targeting, or placement of the delivery system at the target site. The effectiveness of this approach will be illustrated with examples of new treatments for cancer, cardiovascular, and infectious disease.
Sheffield-Sterling-Strathcona Hall | Room: 114 — 1 Prospect Street
